Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 2 - Number 1

Author Index To Volume 1

, 2(1): ii

Bentham Science Publisher


DOI: 10.2174/15748928107020100ii




Subject Index To Volume 1

, 2(1): vi

Bentham Science Publisher


DOI: 10.2174/15748928107020100vi




Therapeutic Transfer of DNA Encoding Adenoviral E1A

, 2(1): 1 - 10

Helmut Deissler and Bertram Opalka


DOI: 10.2174/157489207779561471




Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents

, 2(1): 11 - 29

S. A. Nuno M. F. S. A. Cerqueira, Pedro A. Fernandes and Maria J. Ramos


DOI: 10.2174/157489207779561408




Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development

, 2(1): 31 - 58

Eckhard Baston and Frederic R. Leroux


DOI: 10.2174/157489207779561453




Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

, 2(1): 59 - 71

Anand Veeravagu, Andrew R. Hsu, Weibo Cai, Lewis C. Hou, Victor C.K. Tse and Xiaoyuan Chen


DOI: 10.2174/157489207779561426




New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies

, 2(1): 73 - 78

Floriana Facchetti, Elena Monzani and Caterina A.M. La Porta


DOI: 10.2174/157489207779561390




Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

, 2(1): 79 - 101

Sui X. Cai


DOI: 10.2174/157489207779561462




Patent Annotations

, 2(1): 103 - 105

Bentham Science Publisher


DOI: 10.2174/157489207779561417




Patent Selections

, 2(1): 107 - 108

Bentham Science Publisher


DOI: 10.2174/157489207779561480




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science